GlaxoSmithKline Consumer Healthcare has reached an agreement with Laclede to buy oral healthcare brand Biotene for $170 million (£103.6 million)
Related Topics
Early Stage Funding
GlaxoSmithKline Consumer Healthcare has reached an agreement with Laclede to buy oral healthcare brand Biotene for $170 million (£103.6 million)